Literature DB >> 9287042

Glucose-induced insulin secretion in INS-1 cells depends on factors present in fetal calf serum and rat islet-conditioned medium.

N Sekine1, C Fasolato, W F Pralong, J M Theler, C B Wollheim.   

Abstract

To study the regulation of growth and differentiated function of insulin-secreting cells, the rat insulinoma cell line INS-1 was cultured in a defined serum-free medium containing prolactin, IGF-I, and triiodothyronine, which was originally reported to maintain insulin secretion of islet cells. Growth and viability, as well as cellular insulin content of INS-1 cells in the defined medium, were comparable to the control cells cultured in the complete medium containing 10% fetal calf serum. However, after a 3-day culture in this medium, insulin secretion in response to glucose, pyruvate, and leucine was markedly blunted compared with the control cells (-78, -68, and -56%, respectively), whereas the response to 30 mmol/l K+ was only slightly decreased. In these cells: 1) nutrient metabolism assessed by tetrazolium salt reduction was reduced in response to pyruvate and leucine, which are mainly metabolized in the mitochondria; 2) oxidation of both [3,4-(14)C]glucose and [1-(14)C]pyruvate was decreased (-22 and -32%, respectively); 3) glucose failed to depolarize the membrane potential, whereas tolbutamide was fully active; 4) video imaging analysis of cytosolic Ca2+ showed a decrease in the population of glucose-responsive cells, while the response to 30 mmol/l K+ was preserved; 5) serum replenishment for 3 days restored glucose-induced insulin secretion. Interestingly, conditioned serum-free medium from rat islets maintained the insulin secretory function of INS-1 cells, although glucagon, somatostatin, and some other factors failed to restore the function. In contrast, conditioned media from HepG2, PC12, and human umbilical vein endothelial cells did not substitute for serum. Thus, the impaired insulin secretion of the cells cultured in the defined medium is best explained by defective mitochondrial metabolism. Islet cells, but not INS-1 cells, produce factors required for normal signal generation by nutrient secretagogues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287042     DOI: 10.2337/diab.46.9.1424

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Stimulation of Na,K-ATPase by low potassium is dependent on transferrin.

Authors:  W Yin; G Jiang; K Takeyasu; X Zhou
Journal:  J Membr Biol       Date:  2003-06-01       Impact factor: 1.843

2.  Insights into the role of anaplerosis in insulin secretion: A 13C NMR study.

Authors:  N E Simpson; N Khokhlova; J A Oca-Cossio; I Constantinidis
Journal:  Diabetologia       Date:  2006-03-31       Impact factor: 10.122

3.  β2-Syntrophin is a Cdk5 substrate that restrains the motility of insulin secretory granules.

Authors:  Sandra Schubert; Klaus-Peter Knoch; Joke Ouwendijk; Shabaz Mohammed; Yury Bodrov; Melanie Jäger; Anke Altkrüger; Carolin Wegbrod; Marvin E Adams; Yong Kim; Stanley C Froehner; Ole N Jensen; Yannis Kalaidzidis; Michele Solimena
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

4.  Kir6.2 mutations causing neonatal diabetes prevent endocytosis of ATP-sensitive potassium channels.

Authors:  Jamel Mankouri; Tarvinder K Taneja; Andrew J Smith; Sreenivasan Ponnambalam; Asipu Sivaprasadarao
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

5.  Implication of mitochondrial cytoprotection in human islet isolation and transplantation.

Authors:  Yong Wang; Joshua E Mendoza-Elias; Meirigeng Qi; Tricia A Harvat; Sang Joon Ahn; Dongyoung Lee; Diana Gutierrez; Hyojin Jeon; Daniel Paushter; José Oberholzer
Journal:  Biochem Res Int       Date:  2012-05-07

6.  The Connexin 43 Regulator Rotigaptide Reduces Cytokine-Induced Cell Death in Human Islets.

Authors:  Seyed Mojtaba Ghiasi; Jakob Bondo Hansen; Dan Ploug Christensen; Björn Tyrberg; Thomas Mandrup-Poulsen
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.